OTCMKTS:CBIS - Cannabis Science Stock Price, Price Target & More

$0.0620 +0.01 (+19.23 %)

(As of 04/22/2018 06:20 AM ET)

Previous Close$0.0620

Today's Range$0.0560 - $0.0630

52-Week Range$0.0311 - $0.1397

Volume12.22 million shs

Average Volume20.10 million shs

Market Capitalization$190.59 million

P/E RatioN/A

Dividend YieldN/A

Beta-3.5

About Cannabis Science (OTCMKTS:CBIS)

Cannabis Science, Inc. is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company focuses on the development of governmentally approved pharmaceuticals, including CS-TATI1, CS-S/BCC-1 and neurological therapy under study or development. The Company's subsidiaries include Cannabis Science BV and Cannabis Science International Holding BV.

Receive CBIS News and Ratings via Email

Sign-up to receive the latest news and ratings for CBIS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryCannabis

SectorN/A

SymbolOTCMKTS:CBIS

CUSIPN/A

Webwww.cannabisscience.com

Phone+1-888-8890888

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net Margins-151,408.60%

Return on EquityN/A

Return on Assets-590.52%

Miscellaneous

EmployeesN/A

Outstanding Shares2,520,000,000

How to Become a New Pot Stock Millionaire

Cannabis Science (OTCMKTS:CBIS) Frequently Asked Questions

What is Cannabis Science's stock symbol?

Cannabis Science trades on the OTCMKTS under the ticker symbol "CBIS."

How were Cannabis Science's earnings last quarter?

Cannabis Science Inc. (OTCMKTS:CBIS) announced its quarterly earnings data on Tuesday, July, 28th. The company reported $0.00 earnings per share for the quarter. View Cannabis Science's Earnings History.

Who are some of Cannabis Science's key competitors?

Some companies that are related to Cannabis Science include Legacy Oil Gas (LEGPF), Debenhams (DBHSY), Sevion Therapeutics (SVON), SIRIUS XM CDA HLDG SUB-VTG (SIICF), Countrywide (CYWDF), ADVA Optical Networking (ADVOF), NicOx (NICXF), Medical Marijuana (MJNA), Parkson Retail Gro (PKSGY), Viralytics (VRACY), Telit Communications (TTCNF), Amerisur Resources (ASUXF), Foxtons (FXTGY), MDxHealth (MXDHF), Fission Uranium (FCUUF), Osiris Therapeutics (OSIR), Saba Software (SABA) and Lonmin (LNMIY).

Who are Cannabis Science's key executives?

Cannabis Science's management team includes the folowing people:

Raymond C. Dabney, President, Chief Executive Officer, Director (Age 51)
Benjamin C.K. Tam, Chief Financial Officer, Secretary, Director
Robert Kane, Chief Operating Officer, Director (Age 40)
Mario Lap, Director (Age 64)

Has Cannabis Science been receiving favorable news coverage?

Media stories about CBIS stock have trended positive on Sunday, Accern Sentiment reports. The research group scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cannabis Science earned a news sentiment score of 0.44 on Accern's scale. They also assigned headlines about the company an impact score of 45.71 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Cannabis Science?

Shares of CBIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cannabis Science's stock price today?

One share of CBIS stock can currently be purchased for approximately $0.0620.

How big of a company is Cannabis Science?

Cannabis Science has a market capitalization of $190.59 million.

How can I contact Cannabis Science?

Cannabis Science's mailing address is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. The company can be reached via phone at +1-888-8890888.

MarketBeat Community Rating for Cannabis Science (CBIS)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		73 (Vote Outperform)
Underperform Votes:		67 (Vote Underperform)
Total Votes:		140

MarketBeat's community ratings are surveys of what our community members think about Cannabis Science and other stocks. Vote "Outperform" if you believe CBIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBIS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Cannabis Science (OTCMKTS:CBIS) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Details

(Data available from 4/22/2016 forward)

Cannabis Science (OTCMKTS:CBIS) Earnings History and Estimates Chart

Earnings by Quarter for Cannabis Science (OTCMKTS:CBIS)

Cannabis Science (OTCMKTS CBIS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
4/17/2017	Q4 2016		$0.01			View	N/A
7/28/2015	Q3 2016		($0.0030)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Cannabis Science (OTCMKTS:CBIS) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Cannabis Science (OTCMKTS CBIS) Insider Trading and Institutional Ownership History

Insider Trading History for Cannabis Science (OTCMKTS:CBIS)

Cannabis Science (OTCMKTS CBIS) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/12/2018	Benjamin C.K. Tam	CFO	Sell	193,626	$0.10	$19,362.60
1/3/2018	Robert James Kane	COO	Sell	200,000	$0.13	$26,000.00
12/29/2017	Robert James Kane	COO	Sell	200,000	$0.10	$20,000.00
11/30/2017	Robert James Kane	COO	Sell	198,820	$0.06	$11,929.20
10/20/2016	Robert James Kane	COO	Sell	2,000,000	$0.07	$140,000.00	16,537,665
10/19/2016	Robert James Kane	COO	Sell	4,000,000	$0.04	$160,000.00	18,537,665
10/14/2016	Robert James Kane	CFO	Sell	1,389,577	$0.02	$27,791.54	21,537,665
10/10/2016	Robert James Kane	CFO	Sell	1,783,475	$0.02	$35,669.50	23,710,717
9/13/2016	Robert James Kane	CFO	Sell	2,000,000	$0.01	$20,000.00	24,710,717
5/18/2016	Robert James Kane	CFO	Sell	503,345	$0.02	$10,066.90	24,210,717
5/6/2016	Robert James Kane	CFO	Sell	300,000	$0.02	$6,000.00	24,714,062
3/31/2016	Chad Steven Johnson	COO	Sell	500,000	$0.02	$10,000.00	17,920,323
3/29/2016	Chad Steven Johnson	COO	Sell	2,402,000	$0.02	$48,040.00	18,522,323
3/21/2016	Chad Steven Johnson	COO	Sell	483,852	$0.02	$9,677.04	922,323
3/3/2016	Chad Steven Johnson	COO	Sell	2,188,334	$0.01	$21,883.34	3,030,175
2/29/2016	Chad Steven Johnson	COO	Sell	4,370,000	$0.01	$43,700.00	7,195,509
2/19/2016	Chad Steven Johnson	COO	Sell	1,765,300	$0.01	$17,653.00	8,259,809
12/11/2015	Chad Steven Johnson	COO	Sell	1,646,142	$0.02	$32,922.84	9,659,809
12/3/2015	Chad Steven Johnson	COO	Sell	769,986	$0.02	$15,399.72	11,305,951
12/2/2015	Chad Steven Johnson	COO	Sell	1,852,239	$0.02	$37,044.78	12,075,937
8/19/2015	Chad Steven Johnson	COO	Sell	6,500,000	$0.03	$195,000.00	3,928,176
6/9/2015	Chad Steven Johnson	COO	Sell	1,063,575	$0.03	$31,907.25
4/29/2015	Chad Steven Johnson	COO	Sell	921,333	$0.04	$36,853.32
3/27/2015	Chad Steven Johnson	COO	Sell	1,400,000	$0.04	$56,000.00
3/19/2015	Chad Steven Johnson	COO	Sell	1,262,691	$0.05	$63,134.55
2/4/2015	Chad Steven Johnson	COO	Sell	1,809,914	$0.06	$108,594.84
1/20/2015	Chad Steven Johnson	COO	Sell	255,000	$0.07	$17,850.00
1/14/2015	Dh Bray	CEO	Sell	1,260,750	$0.06	$75,645.00
1/5/2015	Chad Steven Johnson	COO	Sell	1,600,000	$0.07	$112,000.00
11/20/2014	Chad Steven Johnson	COO	Sell	433,990	$0.07	$30,379.30
11/14/2014	Chad Steven Johnson	COO	Sell	251,110	$0.06	$15,066.60
11/3/2014	Chad Steven Johnson	COO	Sell	400,000	$0.09	$36,000.00
10/31/2014	Chad Steven Johnson	COO	Sell	750,000	$0.08	$60,000.00
2/13/2014	Robert Melamede	Major Shareholder	Sell	425,800	$0.17	$72,386.00
2/11/2014	Robert Melamede	Major Shareholder	Sell	779,200	$0.19	$148,048.00
2/6/2014	Robert Melamede	Major Shareholder	Sell	473,300	$0.25	$118,325.00
2/4/2014	Robert Melamede	Major Shareholder	Sell	659,700	$0.19	$125,343.00
1/30/2014	Robert Melamede	Major Shareholder	Sell	600,200	$0.19	$114,038.00
1/27/2014	Robert Melamede	Major Shareholder	Sell	525,000	$0.14	$73,500.00
1/22/2014	Robert Melamede	Major Shareholder	Sell	476,500	$0.11	$52,415.00
1/16/2014	Robert Melamede	Major Shareholder	Sell	425,800	$0.10	$42,580.00
1/13/2014	Robert Melamede	Major Shareholder	Sell	248,800	$0.12	$29,856.00
1/9/2014	Robert Melamede	Major Shareholder	Sell	170,200	$0.13	$22,126.00
1/7/2014	Robert Melamede	Major Shareholder	Sell	132,200	$0.07	$9,254.00
1/3/2014	Robert Melamede	Major Shareholder	Sell	83,300	$0.07	$5,831.00

(Data available from 1/1/2013 forward)

Cannabis Science (OTCMKTS CBIS) News Headlines

Source:

Date	Headline
	Evolab Alchemy Wins 'Best Vape Cartridge' at 2018 Terpenes & Testing World Conference www.prnewswire.com - April 12 at 5:27 PM
	Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County ... globenewswire.com - April 12 at 5:27 PM
	Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply finance.yahoo.com - April 10 at 8:39 AM
	CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company's ... globenewswire.com - March 25 at 6:09 PM
	UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company's Research on the ... globenewswire.com - March 25 at 6:09 PM
	Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27000 Sq. Ft., Bottling Manufacturing Facility for ... - GlobeNewswire (press release) globenewswire.com - March 19 at 8:33 AM
	Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food Containers finance.yahoo.com - March 19 at 8:33 AM
	Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol ... - GlobeNewswire (press release) globenewswire.com - March 14 at 6:54 PM
	Crown Baus Announces Acquisition of Cannabia, the World's First Cannabis Alcoholic Beverage; Will Partner With ... - GlobeNewswire (press release) globenewswire.com - March 14 at 6:54 PM
	Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis Beer finance.yahoo.com - March 14 at 6:54 PM
	Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing ... - GlobeNewswire (press release) globenewswire.com - March 6 at 8:26 AM
	Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals finance.yahoo.com - March 5 at 5:43 PM
	Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social ... - GlobeNewswire (press release) globenewswire.com - March 1 at 8:24 AM
	Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles ... - GlobeNewswire (press release) globenewswire.com - February 23 at 8:34 AM
	Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options finance.yahoo.com - February 22 at 8:30 AM
	Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers finance.yahoo.com - February 2 at 3:55 PM
	Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines finance.yahoo.com - January 31 at 3:49 PM
	Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings finance.yahoo.com - January 30 at 3:50 PM
	Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals finance.yahoo.com - January 18 at 10:34 AM
	Crown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems Integration finance.yahoo.com - January 16 at 5:08 PM
	Insider Selling: Cannabis Science Inc (CBIS) CFO Sells 193,626 Shares of Stock www.americanbankingnews.com - January 13 at 12:14 AM
	Cannabis Science, Expanding its Dispensary Operation and Blockchain finance.yahoo.com - January 9 at 9:41 AM
	Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government ... - GlobeNewswire (press release) globenewswire.com - January 5 at 4:56 PM
	Data Reveals Legal Cannabis Industry Projected to Grow - PR Newswire (press release) www.prnewswire.com - January 4 at 9:38 AM
	Cannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of Stock www.americanbankingnews.com - January 3 at 9:52 PM
	Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO ... - GlobeNewswire (press release) globenewswire.com - January 3 at 8:52 AM
	Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development Programs finance.yahoo.com - January 3 at 8:52 AM
	Cannabis Science Inc (CBIS) COO Sells $20,000.00 in Stock www.americanbankingnews.com - December 29 at 7:00 PM
	Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries ... - GlobeNewswire (press release) globenewswire.com - December 29 at 10:12 AM
	Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries in Los Angeles on Schedule to Open for the Much-Anticipated January 2018 California Market Opening finance.yahoo.com - December 28 at 3:49 PM
	Cannabis Market Begins to Mature in Legal States - PR Newswire (press release) www.prnewswire.com - December 28 at 8:31 AM
	Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other ... - GlobeNewswire (press release) globenewswire.com - December 22 at 9:00 PM
	Cannabis Science Acquires Second PRE ICO Dispensary OTC ... - GlobeNewswire (press release) globenewswire.com - December 22 at 9:00 PM
	Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other Industry Applications finance.yahoo.com - December 22 at 9:00 PM
	Cannabis Science Acquires Second PRE ICO Dispensary finance.yahoo.com - December 20 at 9:43 AM
	Cannabis Science (CBIS) vs. Miragen Therapeutics (MGEN) Head-To-Head Survey www.americanbankingnews.com - December 12 at 11:38 PM
	Comparing Cannabis Science (CBIS) and Miragen Therapeutics (MGEN) www.americanbankingnews.com - December 12 at 5:36 AM
	Cannabis Science (CBIS) versus Miragen Therapeutics (MGEN) Financial Survey www.americanbankingnews.com - December 11 at 6:26 PM
	Cannabis Science Expands its Global Research Consortium by ... - GlobeNewswire (press release) globenewswire.com - December 11 at 5:23 PM
	Cannabis Science (CBIS) & Miragen Therapeutics (MGEN) Financial Analysis www.americanbankingnews.com - December 10 at 7:20 PM
	Analyzing BioTelemetry (BEAT) & Cannabis Science (CBIS) www.americanbankingnews.com - December 7 at 9:24 AM
	Head-To-Head Review: BioTelemetry (BEAT) and Cannabis Science (CBIS) www.americanbankingnews.com - December 6 at 9:38 PM
	Reviewing BioTelemetry (BEAT) & Cannabis Science (CBIS) www.americanbankingnews.com - December 5 at 1:10 AM
	Robert James Kane Sells 198,820 Shares of Cannabis Science, Inc. (CBIS) Stock www.americanbankingnews.com - December 4 at 9:34 PM
	CBIS Reports on November 30, 2017 TRO Hearing and Next Steps; Hearing on a Preliminary Injunction Arguments Based on Information Disregarded by San Joaquin County finance.yahoo.com - December 4 at 5:10 PM
	CBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary ... - Benzinga www.benzinga.com - December 1 at 5:01 PM
	CBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary Restraining Order Hearing for Today, Thursday, November 30, 2017 at 3:30pm in Department 3 of the US District Courthouse, 501 I Street, Sacramento, CA finance.yahoo.com - November 30 at 5:07 PM
	Financial Review: BioTelemetry (BEAT) and Cannabis Science (CBIS) www.americanbankingnews.com - November 29 at 7:30 AM
	Cannabis Science, Inc. Announces the Nearing Completion of a Novel Patentable Formulary Cannabinoid Medication to Treat Asthma/COPD Overlap Syndrome and Clinical Trials to Start Soon finance.yahoo.com - November 28 at 8:22 AM
	Analyzing Signal Genetics (MGEN) & Cannabis Science (CBIS) www.americanbankingnews.com - November 28 at 1:08 AM

Cannabis Science (OTCMKTS:CBIS) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Financials are not available for this stock.

Cannabis Science (OTCMKTS CBIS) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff